Page last updated: 2024-08-26

u 69593 and trk 820

u 69593 has been researched along with trk 820 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, H; Gouda, H; Hirayama, S; Hirono, S; Iwai, T; Kitazawa, S; Nagasea, H; Nemoto, T; Watanabe, Y1
Cheng, J; McCorvy, JD; Tan, L; Yan, W1
Endoh, T; Fujimura, M; Izumimoto, N; Nagase, H; Suzuki, T; Takezawa, Y; Tanaka, T; Togashi, Y1
Leitermann, RJ; Mizoguchi, H; Nagase, H; Narita, M; Suzuki, T; Tseng, LF1

Reviews

1 review(s) available for u 69593 and trk 820

ArticleYear
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship

2018

Other Studies

3 other study(ies) available for u 69593 and trk 820

ArticleYear
Design, synthesis, and structure-activity relationship of novel opioid κ receptor selective agonists: α-iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.
    Bioorganic & medicinal chemistry letters, 2014, Nov-01, Volume: 24, Issue:21

    Topics: Amides; Aza Compounds; Bridged Bicyclo Compounds; Drug Design; Humans; Molecular Conformation; Molecular Structure; Protein Binding; Receptors, Opioid, kappa; Structure-Activity Relationship

2014
Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions.
    Brain research, 2004, Jan-09, Volume: 995, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzeneacetamides; Drug Tolerance; Male; Mice; Morphinans; Morphine; Motor Activity; Pain Measurement; Pyrrolidines; Receptors, Opioid, kappa; Spiro Compounds

2004
Region-dependent G-protein activation by kappa-opioid receptor agonists in the mouse brain.
    Neuroscience letters, 2004, Feb-12, Volume: 356, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzeneacetamides; Brain; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Morphinans; Naltrexone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, kappa; Spiro Compounds

2004